M

Maze Therapeutics

Clinical-stage biotech developing precision kidney therapies

Senior Medical Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • MD with at least 6 years of drug development industry experience.
  • Board eligibility or certification and clinical experience in internal medicine and/or pediatrics.
  • Experience as a clinical study medical monitor.
  • Experience preparing and submitting scientific publications, study protocols, Investigator Brochures, and other clinical-regulatory documents.
  • Experience planning and overseeing early-stage and/or registration-enabling clinical development programs, including CRO and site selection and relationship building with investigators, site study staff, patient advocacy groups, and other third parties.
  • Knowledge and experience designing and conducting clinical trials and analyzing and interpreting clinical data, particularly Phase 2 trials.
  • Experience leading a cross-functional study team.
  • Ability to nurture relationships with investigators, site study staff, patient advocacy groups, and other third parties to support clinical programs and broader company objectives.
  • Organizational, analytical, and communication skills to translate corporate objectives into actionable plans and deliver high-quality data on time and within budget.
  • Adaptability to changing environments and adherence to personal and ethical standards.
  • Willingness to travel domestically and internationally up to 20% for vendor visits, industry conferences, regulatory meetings, advisory boards, and other essential gatherings.

Responsibilities

  • Lead the design, execution, and analysis of clinical trials for the SLC6A19 program and other early-stage clinical assets.
  • Author and review clinical-regulatory documents, including protocols and amendments, informed consents, study reports, and statistical analysis plans.
  • Prepare and deliver scientific presentations and other communication materials for internal and external stakeholders, including investigators and collaborators.
  • Engage with scientific thought leaders and patient advocacy groups to gather insights for clinical development plans and build awareness of pipeline assets.
  • Partner with Clinical Development Operations to identify and select study investigators and sites and build professional relationships with investigators.
  • Partner with Clinical Development Operations to identify, select, and oversee vendors and CROs supporting program needs.
  • Develop and integrate timelines and budgets for clinical activities with company timelines and goals, coordinating with project management, CMC, nonclinical development, regulatory affairs, and other stakeholders.
  • Build communication channels across the organization and influence senior management decisions through persuasive arguments.
  • Address differing opinions respectfully to support decisions; champion partnerships and proactively address issues that could disrupt team relationships.
  • Recognize team and individual contributions in public forums.
  • Address gaps, leverage strengths, clarify priorities during change, and remove barriers that put functional or corporate goals at risk.
  • Remove barriers to staff development and empower staff to make decisions; keep direct reports prepared and responsive to industry trends.

Desired Qualifications

  • Clinical or research experience in nephrology or cardiometabolic diseases.

About the Company

Maze Therapeutics

Clinical-stage biotech developing precision kidney therapies

Maze Therapeutics is a clinical-stage biotechnology company that builds precision medicines for diseases with large unmet needs by using human genetics to copy protective genetic variants into small-molecule drugs. Its Compass platform maps genetic insights to therapeutic targets through variant functionalization, guiding drug discovery across research, preclinical, and clinical stages. Its lead program MZE829 targets APOL1-driven kidney disease, while MZE782 is in development for chronic kidney disease and phenylketonuria. Unlike many peers, Maze focuses on turning natural genetic protections into medicines and aims to develop and commercialize its own therapies.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Maze Therapeutics

See more jobs